News & stories

News | Sep 23, 2024

Diabetes medication must be made affordable and accessible

Eli Lilly, Novo Nordisk, and Sanofi must drop their prices and stop blocking generic manufacturers from entering the market.

Story | Sep 18, 2023

The long and winding road to affordable access to a key TB drug

Christophe Perrin, the MSF Access Campaign‘s TB advocacy pharmacist, discusses the need for secure affordable access to improved TB medicines.

News | Sep 12, 2023

J&J and Cepheid must expand access to TB drug and tests

TB is curable but remains the world’s leading infectious disease killer as pharma corporations stand in the way of affordable medical tools

News | Sep 05, 2023

South Africans prepare for cholera outbreaks amid climate change

As climate change increases the frequency and scale of cholera outbreaks, MSF is training health and disaster management workers to respond.

Story | Mar 23, 2023

How to end TB: Teach it at school

MSF has developed a TB education curriculum that empowers educators and learners to become TB advocates.

News | Mar 23, 2023

MSF applauds rejection of J&J attempt to extend TB drug patent

The rejection of the salt form of bedaquiline is welcome news for people with drug-resistant tuberculosis.

News | Dec 21, 2022

MSF trial finds better treatment for people with TB

Results published in the New England Journal of Medicine today show that a much shorter treatment regimen for drug-resistant TB is safer and cured almost 90 percent of patients

News | Nov 29, 2022

MSF: ViiV must make groundbreaking HIV prevention injection affordable and available

Removing barriers that block access to this medicine could help avoid millions of new HIV infections.

Story | Jun 14, 2022

Video: Communities use music to cope after devastating floods in South Africa

News | Apr 29, 2022

South Africa: Survivors of severe flash floods are in urgent need of water, aid